ACUTE-PHASE EFFICACY IN A PHASE 3 MULTICENTER, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF ZS-9 FOR HYPERKALAEMIA

被引：0
|
作者：
El-Shahawy, Mohamed A. [1 ]
Rasmussen, Henrik S. [2 ]
Lavin, Philip T. [3 ]
Yang, Alex [4 ]
Packham, David K. [5 ]
机构：
[1] Acad Med Res Inst, Los Angeles, CA USA
[2] ZS Pharma Inc, Coppell, TX USA
[3] Boston Biostat Res Fdn, Framingham, MA USA
[4] Xelay Acumen Inc, Belmont, CA USA
[5] Melbourne Renal Res Grp, Melbourne, Vic, Australia
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2014年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
SP320
引用
收藏
页码：178 / 178
页数：1
相关论文
共 50 条
  • [41] Efficacy and safety of ginsenoside-Rd for acute ischaemic stroke: a randomized, double-blind, placebo-controlled, phase II multicenter trial
    Liu, X.
    Xia, J.
    Wang, L.
    Song, Y.
    Yang, J.
    Yan, Y.
    Ren, H.
    Zhao, G.
    EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 (05) : 569 - 575
  • [42] Lubeluzole in acute ischemic stroke - A double-blind, placebo-controlled phase II trial
    Diener, HC
    Hacke, W
    Hennerici, M
    Radberg, J
    Hantson, L
    DeKeyser, J
    STROKE, 1996, 27 (01) : 76 - 81
  • [43] EFFICACY AND SAFETY OF DUPILUMAB IN THE TREATMENT OF MODERATE-TO-SEVERE ATOPIC DERMATITIS IN CHINESE ADULTS: A MULTICENTER, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 3 TRIAL
    Zhao, Yan
    Wu, Liming
    Lu, Qianjin
    Gao, Xinghua
    Zhu, Xiaohong
    Yao, Xu
    Li, Linfeng
    Li, Wei
    Ding, Yangfeng
    Song, Zhiqiang
    Liu, Lingling
    Dang, Ningning
    Zhang, Chunlei
    Liu, Xiaoming
    Gu, Jun
    Wang, Jinyan
    Geng, Songhai
    Liu, Qunazhong
    Guo, Yifeng
    Lv, Dong
    Ren, Gong
    Yang, Xiumin
    Deng, Danqi
    Li, Shanshan
    Han, Xiuping
    Biao, Shuzhen
    Zheng, Min
    Dong, Li
    Su, Huijuan
    Bai, Lili
    O'Malley, John T.
    Luo, Junxiang
    Zhang, Jianzhong
    ACTA DERMATO-VENEREOLOGICA, 2021, 101 : 58 - 58
  • [44] Oral rimegepant for preventive treatment of migraine: a phase 2/3, randomised, double-blind, placebo-controlled trial
    Croop, Robert
    Lipton, Richard B.
    Kudrow, David
    Stock, David A.
    Kamen, Lisa
    Conway, Charles M.
    Stock, Elyse G.
    Coric, Vladimir
    Goadsby, Peter J.
    LANCET, 2021, 397 (10268): : 51 - 60
  • [45] Cytisine for smoking cessation in patients with tuberculosis: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial
    Dogar, Omara
    Keding, Ada
    Gabe, Rhian
    Marshall, Anna-Marie
    Huque, Rumana
    Barua, Deepa
    Fatima, Razia
    Khan, Amina
    Zahid, Raana
    Mansoor, Sonia
    Kotz, Daniel
    Boeckmann, Melanie
    Elsey, Helen
    Kralikova, Eva
    Parrott, Steve
    Li, Jinshuo
    Readshaw, Anne
    Sheikh, Aziz
    Siddiqi, Kamran
    LANCET GLOBAL HEALTH, 2020, 8 (11): : E1408 - E1417
  • [46] Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial
    Tremoulet, Adriana H.
    Jain, Sonia
    Jaggi, Preeti
    Jimenez-Fernandez, Susan
    Pancheri, Joan M.
    Sun, Xiaoying
    Kanegaye, John T.
    Kovalchin, John P.
    Printz, Beth F.
    Ramilo, Octavio
    Burns, Jane C.
    LANCET, 2014, 383 (9930): : 1731 - 1738
  • [47] Efficacy and Safety of Stempeucel in Osteoarthritis of the Knee: A Phase 3 Randomized, Double-Blind, Multicenter, Placebo-Controlled Study
    Gupta, Pawan Kumar
    Maheshwari, Sunil
    Cherian, Joe Joseph
    Goni, Vijay
    Sharma, Arun Kumar
    Tripathy, Sujith Kumar
    Talari, Keerthi
    Pandey, Vivek
    Sancheti, Parag Kantilal
    Singh, Saurabh
    Verma, Nikhil N.
    Kumar, Uday
    AMERICAN JOURNAL OF SPORTS MEDICINE, 2023, 51 (09): : 2254 - 2266
  • [48] Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial
    Boxer, Adam L.
    Lang, Anthony E.
    Grossman, Murray
    Knopman, David S.
    Miller, Bruce L.
    Schneider, Lon S.
    Doody, Rachelle S.
    Lees, Andrew
    Golbe, Lawrence I.
    Williams, David R.
    Corvol, Jean-Cristophe
    Ludolph, Albert
    Burn, David
    Lorenzl, Stefan
    Litvan, Irene
    Roberson, Erik D.
    Hoeglinger, Guenter U.
    Koestler, Mary
    Jack, Clifford R., Jr.
    Van Deerlin, Viviana
    Randolph, Christopher
    Lobach, Iryna V.
    Heuer, Hilary W.
    Gozes, Illana
    Parker, Lesley
    Whitaker, Steve
    Hirman, Joe
    Stewart, Alistair J.
    Gold, Michael
    Morimoto, Bruce H.
    LANCET NEUROLOGY, 2014, 13 (07): : 676 - 685
  • [49] Eprotirome in patients with familial hypercholesterolaemia (the AKKA trial): a randomised, double-blind, placebo-controlled phase 3 study
    Sjouke, Barbara
    Langslet, Gisle
    Ceska, Richard
    Nicholls, Stephen J.
    Nissen, Steven E.
    Ohlander, Maria
    Ladenson, Paul W.
    Olsson, Anders G.
    Hovingh, G. Kees
    Kastelein, John J. P.
    LANCET DIABETES & ENDOCRINOLOGY, 2014, 2 (06): : 455 - 463
  • [50] Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial
    Han, Joseph K.
    Bachert, Claus
    Fokkens, Wytske
    Desrosiers, Martin
    Wagenmann, Martin
    Lee, Stella E.
    Smith, Steven G.
    Martin, Neil
    Mayer, Bhabita
    Yancey, Steven W.
    Sousa, Ana R.
    Chan, Robert
    Hopkins, Claire
    LANCET RESPIRATORY MEDICINE, 2021, 9 (10): : 1141 - 1153
12345